Tag - pharmaceuticals

 
Menu
Search
 
April 10, 2025
 

Today's print edition

Home Delivery
Subscribe for more access

PHARMACEUTICALS

Japan Times
WORLD / Science & Health
Apr 12, 2022
India hopes ‘Pharma City’ will break China’s grip on industry
It's a vast project that shows how governments are growing increasingly concerned about China's stranglehold over drug supplies — as well as the challenges they face in loosening it.
Japan Times
WORLD
Mar 29, 2022
World moves from shortages to possible glut of COVID-19 vaccines
Even as boosters are likely to keep demand alive for COVID-19 inoculations worldwide, the desperate shortages that existed for much of last year have waned.
BUSINESS / Companies
Mar 25, 2022
Shionogi signs supply deal with Japanese government for COVID-19 pill
The government is considering buying a million doses of the drug, pending regulatory approval.
Japan Times
BUSINESS / Companies
Mar 23, 2022
With sumo flag sponsorship deal, COVID vaccine-maker Moderna reveals Japan ambition
The U.S. firm is seeking to build on its newfound renown in COVID-19 vaccines and wrestle market share from compatriot Pfizer Inc.
Japan Times
WORLD
Mar 16, 2022
U.S., EU, India and South Africa near deal on intellectual property waiver for COVID vaccines
The tentative agreement does not include COVID-19 treatments or tests, and also has limitations likely to exclude China from any waiver, according to one source.
Japan Times
WORLD / Science & Health
Mar 16, 2022
Pfizer asks U.S. regulator to clear another booster for older adults
The drugmaker and its partner BioNTech have submitted data to the FDA from Israel, which began offering a fourth shot to older people and health care workers last year.
Japan Times
BUSINESS
Mar 15, 2022
Drugmakers pause trials in Russia while still sending medicine
Major pharmaceutical firms are seeking to strike a balance between international opprobrium over Russia's invasion of Ukraine and the needs of sick patients.
Japan Times
JAPAN
Mar 11, 2022
Fujifilm to halt enrollment in Avigan trial for COVID-19
The emergence of the omicron variant, which usually causes milder infections, made it tough to determine the drug's effectiveness in preventing severe symptoms, the company said.
JAPAN
Mar 6, 2022
Shionogi says its COVID-19 shot is effective and safe
The positive data could mean Japan, which is racing to complete a booster drive in hopes of curbing future outbreaks, will soon have an indigenous jab.
Japan Times
BUSINESS / Companies
Feb 25, 2022
Japan’s petrochemical firms need to merge to survive, Mitsubishi Chemical CEO says
Jean-Marc Gilson compared the situation facing the chemical industry to other industries Japan once dominated, such as semiconductors and flat-screen televisions.
JAPAN / Science & Health
Feb 25, 2022
Shionogi seeks approval for Japan’s first domestic COVID pill
Kishida has signaled that the central government will expedite the review process to pave the way for a swift approval if the drug's efficacy and safety are confirmed.
Japan Times
ASIA PACIFIC
Feb 15, 2022
China’s approval of Pfizer pill opens door to ending 'COVID zero'
Having an effective anti-viral in its arsenal could help China mitigate the lower efficacy of its homegrown vaccines if the virus was allowed to circulate more freely.
Japan Times
WORLD
Feb 14, 2022
Here’s what the pandemic has in store for the world next
As a virus-weary world limps through the third year of the outbreak, experts warn that omicron won't be the last variant we have to contend with.
Japan Times
WORLD
Feb 4, 2022
COVID’s endemic shift means a slowdown for virus product makers
Demand for at-home tests will probably slow first while sales of more reliable PCRs will show more resilience, according to medical supply executives.
Japan Times
WORLD / Science & Health
Feb 3, 2022
The COVID-19 vaccine we need now may not be a shot
Nasal vaccines may be the best way to prevent infections long term, because they provide protection exactly where it is needed to fend off the virus: the mucosal linings of the airways.
Japan Times
WORLD / Science & Health
Feb 1, 2022
How does Merck's COVID-19 pill compare to Pfizer's?
Pfizer said final trial results showed that its treatment reduced the chance of hospitalization or death by 89%, while Merck said their pill reduced those chances by 30%.
Japan Times
WORLD
Jan 27, 2022
Moderna starts trial for omicron-specific booster shot
The news comes a day after rival vaccine developer Pfizer Inc. launched a similar trial.
Japan Times
WORLD
Jan 26, 2022
Pfizer and BioNTech launch trial of omicron-targeted COVID-19 vaccine
The companies plan to test the immune response generated by the omicron-based vaccine both as a three-shot regimen in unvaccinated people and as a booster shot.
Wall Street will regret helping the world burn
Wall Street banks, under political pressure and tempted by short-term gains, are abandoning climate commitments and pouring billions into fossil fuels, risking both environmental catastrophe and massive future economic losses.
Trump's tariff gambit leaves Asia stunned and scrambling
U.S. President Donald Trump speaks as he attends the National Republican Congressional Committee dinner in Washington on Tuesday. Trump allowed new tariffs — including a 24% levy on Japan — to go into effect as scheduled on Wednesday.
Japan and U.S. appoint tariff negotiators after Ishiba-Trump phone call
Economic revitalization minister Ryosei Akazawa enters the Prime Minister's Office in Tokyo on Tuesday.
Japanese makers rush to mitigate possible Nankai Trough earthquake damage
Toyota is considering transferring some production in the key Tokai region, which is expected to be hit hard in a Nankai Trough earthquake, to the Tohoku and Kyushu regions.
Why Japan is running out of rice — and farmers to grow it
An ongoing shortage of rice has resulted in rising prices for Japan's main food staple.
After a tumultuous buildup, a first look at the Osaka Expo
A large statue of Osaka Expo mascot Myaku Myaku sits near the east entrance of the event's venue in Yumeshima island, Osaka, on Wednesday.
Japan gets a new U.S. ambassador — and he has his work cut out for him
George Glass, U.S. President Donald Trump's pick to be ambassador to Japan, attends a Senate Foreign Relations Committee confirmation hearing in Washington on March 13.
Online art scene eager to go offline, at least for the moment
Digital artist Polygon1993 revels in the physicality of nostalgic technology, making art out of materials such as miniature CDs, holographic prints layered with plexiglass shards and a giant custom-made floppy disk.
Tottori takes a bold leap forward in the arts
The city of Kurayoshi in Tottori Prefecture celebrated the opening of its public art museum with festivities such as a parade that drew 1,000 revelers.
Haruki Murakami TV adaptation revisits 30 years of watershed moments
Though Haruki Murakami's trademark whiff of offbeat existentialism is threaded throughout NHK's "After the Quake," the final episode — conceived as a sequel to the story "Super-Frog Saves Tokyo" — is the most stylized, featuring an anthropomorphic talking frog (voiced by Non) and his erstwhile associate Katagiri (Koichi Sato).

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

An ongoing shortage of rice has resulted in rising prices for Japan's main food staple.
Why Japan is running out of rice — and farmers to grow it
By Alex K.T. Martin

SUSTAINABLE JAPAN

BOARDING & INTERNATIONAL SCHOOL DAY 2025 (Sunday, April 20)
BOARDING & INTERNATIONAL SCHOOL DAY 2025 (Sunday, April 20)

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER